Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies - Wikidata - wikimedia - TriplyDB

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

http://www.wikidata.org/entity/Q34062347

about

Early lesions of follicular lymphoma: a genetic perspective.Human Adipose-Derived Mesenchymal Stem Cells in Cell Therapy: Safety and Feasibility in Different "Hospital Exemption" Clinical Applications.Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma.Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction: Clinical Proof of Concept PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.Application of a three-dimensional graft of autologous osteodifferentiated adipose stem cells in patients undergoing minimally invasive transforaminal lumbar interbody fusion: clinical proof of concept.Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients.

P2860

Q35026859-9C45E39E-C3BF-44E9-95B0-0EDD95DF7046 Q35814737-ACAC4D09-5BE7-4419-9C22-D48220E758D6 Q36351646-35314547-FB60-413C-A9A8-7D4217BA9901 Q37328298-5766B928-A246-4B1D-938E-A1309AC4D230 Q42623661-62809065-A6C4-4AAD-A5C6-FC606B646388 Q49912597-59BFC39B-6783-4ECF-B1B4-173D6CAA67BA Q50980351-5843A764-29B9-4973-AB70-B48456FF4500 Q51825432-AC362D4C-4F87-4E05-81F2-DFB36764090E

P2860

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

http://www.wikidata.org/entity/Q34062347

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@ast

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@en

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@nl

type

label

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@ast

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@en

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@nl

prefLabel

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@ast

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@en

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@nl

P1433

Q34062347-4F4EA937-EC51-45A7-8F9E-74710E3407F2

P1476

Q34062347-1A2B8347-DE6E-4020-B8D4-508855A00AAA

P2093

Q34062347-1F08E292-A6D9-4C13-8FCF-E11572A53302

Q34062347-42593A1A-4250-4933-9F9A-37DDB912B0A3

Q34062347-49100FC3-CBCF-49AA-988E-A0CD9484B379

Q34062347-51DA0E91-ACA6-418E-9FFF-31677E39D54D

Q34062347-53BE2091-822F-4229-A374-991A8BAB56B9

Q34062347-5DC53935-6181-4DB9-A304-BFEB1E7C5487

Q34062347-62AB8498-685B-40C5-BF18-D8918A6C8295

Q34062347-62DA4060-EB9F-4B5B-A56A-58D7F3409B64

Q34062347-6342DA81-7E9F-48EF-8837-42F3122C2792

Q34062347-712D14DA-7285-4D57-A940-3B5CA7266E84

P2860

Q34062347-00AF746F-12AA-4968-AB45-CDBB6424C033

Q34062347-075578CB-965E-42AF-8E26-A7FE7591F32A

Q34062347-0CB18F9E-0DF8-4F75-BAE6-7182B2172334

Q34062347-245DF0B5-F491-4649-A678-C560E347601B

Q34062347-247741F2-DF31-4645-8E7B-D9FD1BD3076B

Q34062347-275B4FAE-2921-4DFF-B679-83EEBA8F96E5

Q34062347-2B9E3D8B-D2A5-485E-82EA-20BA00B5343D

Q34062347-2C5FDE18-DB96-4F42-91B8-8D177C8348E7

Q34062347-2F0AD60C-F8FD-494F-AC0E-92EB0690A863

Q34062347-341DDD51-33FA-4462-868F-4BCA8D589C0C

P304

Q34062347-AF6BAED4-A9B8-4983-8BEF-34243B10C047

P31

Q34062347-44A6E056-D47D-4301-BE9A-D87551E03B23

P356

Q34062347-01711FB6-7E1E-4B61-BBEB-8820576C791A

P407

Q34062347-0496235C-3957-484B-B0FB-02C36455AC4E

P433

Q34062347-D40CAAAE-503A-4C20-8B43-21E5D84AC090

P478

Q34062347-68AC9E63-5097-495E-802E-3BF009159DEA

P50

Q34062347-2694D830-A24E-4A67-9C63-E7427E6EF0D4

Q34062347-368E9BD6-92D7-4242-ACB2-DFF9CE1FDCE8

Q34062347-89D70008-F619-427B-98E8-0EEE7F898AFF

Q34062347-9437B916-93EB-444F-B10D-DB8F11FADC1A

Q34062347-94639EAF-0A09-4A5A-972D-E86784339E30

Q34062347-DF63C670-77A1-4176-8694-278518C8CAAA

Q34062347-E1B2C034-17CB-4B79-B611-EF1C90D9EDF6

Q34062347-EF6BE2E7-AEA9-4249-8EB0-F6A760A6F341

P577

Q34062347-956BE8D0-F1F7-42B8-A75F-C67C755E6081

P5875

Q34062347-21C4D726-D993-462D-8A16-C59FD6943CE1

P698

Q34062347-B699DA29-EB55-4207-82A3-668D106C538C

P932

Q34062347-93A43784-6490-47EF-9F61-02598D0E0DDC

P356

JOURNAL.PONE.0026311

P1433

P1476

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

@en

P2093

An De Weer

http://www.w3.org/2001/XMLSchema#string

Anabelle Decottignies

http://www.w3.org/2001/XMLSchema#string

Belgian Cytogenetic Group for Hematology and Oncology (BCG-HO)

http://www.w3.org/2001/XMLSchema#string

Christian Herens

http://www.w3.org/2001/XMLSchema#string

Christine Terré

http://www.w3.org/2001/XMLSchema#string

Elise Chapiro

http://www.w3.org/2001/XMLSchema#string

Elise Labis

http://www.w3.org/2001/XMLSchema#string

Eric Lippert

http://www.w3.org/2001/XMLSchema#string

Francine Mugneret

http://www.w3.org/2001/XMLSchema#string

Frédéric Lambert

http://www.w3.org/2001/XMLSchema#string

P2860

Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal development

Defining the human deubiquitinating enzyme interaction landscape

A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma

A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.

Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis.

Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.

Del 1p36 syndrome: a newly emerging clinical entity.

Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus.

P304

e26311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0026311

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Iwona Wlodarska

Catherine Roche-Lestienne

Marie-Joëlle Mozziconacci

Florence Nguyen-Khac

Francois P. Duhoux

P577

2011-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51754028

http://www.w3.org/2001/XMLSchema#string

P698

22039459

http://www.w3.org/2001/XMLSchema#string

P932

3198844

http://www.w3.org/2001/XMLSchema#string